Page last updated: 2024-09-03

sgb 1534 and Muscle Contraction

sgb 1534 has been researched along with Muscle Contraction in 5 studies

*Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. [MeSH]

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishikawa, S1
Koga, T; Sakai, K; Shiraki, Y1
Aono, J; Ishizuka, N; Nabata, H; Sakai, K1
Flores, F; Follmer, C; Ishida, Y; Satake, N; Shibata, S; Suh, TK; Ueda, S1
Aono, J; Sakai, K1

Other Studies

5 other study(ies) available for sgb 1534 and Muscle Contraction

ArticleYear
Effects of a new alpha 1-adrenoceptor blocking agent, 3-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-(1H,3H)-quinazoline-2, 4-dione monohydrochloride (SGB1534), on electrical and mechanical properties of guinea-pig mesenteric artery.
    Japanese journal of pharmacology, 1984, Volume: 35, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Electric Stimulation; Female; Guinea Pigs; Histamine; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Quinazolines; Serotonin; Synaptic Transmission

1984
Characterization of a novel alpha 1-adrenoceptor antagonist, SGB-1534, in contractile response of isolated canine arterial and venous smooth muscle to exogenous noradrenaline: comparison with prazosin, phentolamine and yohimbine.
    Japanese journal of pharmacology, 1989, Volume: 50, Issue:2

    Topics: Adrenergic alpha-Antagonists; Animals; Dogs; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phentolamine; Prazosin; Quinazolines; Yohimbine

1989
Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
    Archives internationales de pharmacodynamie et de therapie, 1985, Volume: 277, Issue:1

    Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Antihypertensive Agents; Decerebrate State; Gastric Fundus; Guinea Pigs; In Vitro Techniques; Ketanserin; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Piperidines; Prazosin; Quinazolines; Rats; Rats, Inbred Strains; Serotonin Antagonists

1985
Potent alpha-adrenoceptor blocking action of SGB-1534, a new quinazoline antihypertensive agent in vitro experiments.
    General pharmacology, 1986, Volume: 17, Issue:2

    Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Basilar Artery; Cats; Coronary Vessels; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Prazosin; Quinazolines; Rabbits; Vas Deferens

1986
Investigations into the mechanism of the antihypertensive effect of SGB-1534, a novel alpha 1-adrenoceptor antagonist, in rats.
    Japanese journal of pharmacology, 1988, Volume: 48, Issue:2

    Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Clonidine; Heart Rate; In Vitro Techniques; Male; Muscle Contraction; Phenylephrine; Prazosin; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine

1988